Clariane SE (LON:0OPS)
London · Delayed Price · Currency is GBP · Price in EUR 4.401
+0.103 (2.40%)
At close: Sep 12, 2025
Clariane SE Market Cap
Clariane SE has a market cap or net worth of 1.34 billion as of September 15, 2025. Its market cap has increased by 149.62% in one year.
Market Cap
1.34B
Enterprise Value
8.07B
Revenue
4.55B
Ranking
n/a
PE Ratio
n/a
Stock Price
4.40
Market Cap Chart
Since November 24, 2006, Clariane SE's market cap has increased from 527.71M to 1.34B, an increase of 154.28%. That is a compound annual growth rate of 5.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 1.34B | 118.34% |
| Dec 31, 2024 | 614.59M | 175.90% |
| Dec 29, 2023 | 222.76M | -76.49% |
| Dec 30, 2022 | 947.41M | -61.61% |
| Dec 31, 2021 | 2.47B | -16.31% |
| Dec 31, 2020 | 2.95B | 0.38% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 182.89B |
| GSK plc | 60.53B |
| Haleon | 32.39B |
| Smith & Nephew | 12.20B |
| ConvaTec Group | 4.79B |
| Hikma Pharmaceuticals | 3.61B |
| HUTCHMED (China) | 2.23B |
| Genus | 1.72B |